Main Navigation
 
Search
Advanced Search>>
Free Newsletter
Subscribe
Unsubscribe
 
 
  
Health Headlines

Get the latest news in prevention and health matters. This feature includes daily postings and recent archives to keep you up to date on health reports and wires around the world.
Weekly Wellness
Get informed with weekly wellness facts in a diversity of health topics from prevention to fitness and nutrition.
Tips
Great tips on what you need to know about keeping healthy and active all year round.

 

Gene Discovery Links
Smoking and Colorectal Cancer


NEW YORK (Reuters Health) - People who have a genetic mutation previously linked to emphysema are three times more likely to develop a certain type of colorectal cancer than those without the defect, study results suggest. And smokers with the defect may be 20 times more likely to develop the cancer, researchers warn.

``There has been a lot of controversy surrounding whether smoking and colorectal cancer are related,'' Dr. Ping Yang told Reuters Health. ``This study confirms a strong relationship between the two in a group of colorectal cancers.'' Yang is a clinical epidemiologist at the Mayo Clinic in Rochester, Minnesota.

The mutation is in the gene for alpha-1 antitrypsin, a substance that neutralizes protein-destroying enzymes. People who have the gene mutation are more likely to develop emphysema--particularly if they smoke--and are at greater risk of liver and bladder cancer.

In the new study, Yang and colleagues looked at alpha-1 antitrypsin genes in 161 patients with cancers of the colon or rectum and 191 people the same age who were cancer-free.

The investigators found that 22% of the colorectal cancer patients with a specific type of tumor had mutations in the alpha-1 antitrypsin gene, compared with just 9% of the other colorectal cancer patients and 9% of those who were cancer-free, according to the report in the December issue of Molecular Genetics and Metabolism.

``We believe almost 30% of all cases of colorectal cancer may be associated with a lack of alpha-1 antitrypsin,'' Yang said. Smokers with a mutation in the alpha-1 antitrypsin gene were 20 times as likely to develop the subtype of colorectal cancer compared with nonsmokers who did not have the gene mutation, the report indicates.

Lack of alpha-1 antitrypsin may encourage the development of colorectal cancer by allowing chronic tissue damage to accumulate. Over time, such tissue damage may result in the formation of cancers. Cigarette smoking may promote the process, the researchers suggest.

``One thing people can do right away to reduce their risk of colorectal cancer is not smoke, and quit if they do,'' Yang said. ``Smokers should be aware that their risk of lung cancer and heart disease is elevated, and so is their risk of colorectal cancer.''

SOURCE: Molecular Genetics and Metabolism 2000;71:639-645.
Reference Source 89

Select a Channel